Home › Funds › Sequent Asset Management, LLC › ABT

Sequent Asset Management, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Sequent Asset Management, LLC reported holding 5,718 shares of ABT (ABBOTT LABORATORIES) in its Q2 2026 13F filing — a position valued at US$519K, representing 0.65% of its reported portfolio and ranking #30 among its reported holdings. Sequent Asset Management, LLC has disclosed ABT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)5.72K sh
Reported value held$518.85K
Portfolio Weight0.65%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Sequent Asset Management, LLC's ABT position evolved

Sequent Asset Management, LLC first disclosed a stake in ABT in Q3 2023 at 6,737 shares (US$652K). The position peaked in Q2 2025 at 6,120 shares, worth US$832K. Across 12 filings, Sequent Asset Management, LLC increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 5,718 shares valued at US$519K — a reduction of -557 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 6.74K $652.48K New
Q4 2023 6.41K $705.22K Reduce
Q1 2024 6.28K $713.00K Reduce
Q2 2024 6.12K $635.93K Reduce
Q3 2024 6.12K $697.74K Hold
Q4 2024 6.12K $692.23K Hold
Q1 2025 6.12K $811.82K Hold
Q2 2025 6.12K $832.38K Hold
Q3 2025 6.12K $819.71K Hold
Q4 2025 6.28K $787.00K Add
Q1 2026 6.28K $644.25K Hold
Q2 2026 5.72K $518.85K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Sequent Asset Management, LLC held ABT?

Sequent Asset Management, LLC has disclosed ABT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Sequent Asset Management, LLC's current position in ABT?

As of Q2 2026, Sequent Asset Management, LLC holds 5.72K shares of ABT (ABBOTT LABORATORIES), valued at $518.85K, representing 0.65% of its reported portfolio and ranking #30.

Has Sequent Asset Management, LLC been buying or selling ABT?

In the latest 13F filing (Q2 2026), Sequent Asset Management, LLC reduced its position in ABT. The position peaked in Q2 2025 at 6.12K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.